Get started
ABBOTT LABORATORIES COM NPVABBOTT LABORATORIES COM NPVABBOTT LABORATORIES COM NPV

ABBOTT LABORATORIES COM NPV

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

0Q15 trade ideas

Abbott Labs sinking it down the sink. ABTImmediate targets 112, 109. Invalidation 133. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
NYSE:ABTShort
by Rykin_Capital
Abbott divergent. ABTShort term outlook. Bearish outlook for gains at125, then 119. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NYSE:ABTShort
by Rykin_Capital
List of US stocks setting up VCPs for possible long entriesResult of our VCPSniper analysis helping us (and you) to quickly scan through 1000s of names to create a short list of actionable stocks. We always look for price tightness and trend template criteria as defined by Mark Minervini. We publish videos couple of times a week and also add additional analysis on stock by stock basis. The entry should be at the break of the VCP and stop loss MUST be always in place. Your entry needs to take into account your risk appetite. Do not chase stocks that gapped up! There will be another day!.
NYSE:ABTLong
by MojePieniadze
Offshore Watchlist: Abbott Labs (ABT)Offshore - Abbott Laboratories (ABT, $128.45) Sector: Healthcare: Medical Devices Recently raised annual outlook while reporting earnings above analyst estimates. Abbott raised its outlook for 2021 adjusted earnings from continuing operations to between $5.00 and $5.10 per share, compared with its previous forecast of $4.30 to $4.50 per share. On an adjusted basis, the company earned $1.40 per share, beating estimates of 95 cents per share, according to Refinitiv IBES data. Technical Setup: Consolidating below year-to-date highs while developing a pennant. I like it +$130, with a stop of $123.40.
NYSE:ABTLong
by LD_Perspectives